Literature DB >> 10544136

Formation of a ribonucleoprotein complex of mouse hepatitis virus involving heterogeneous nuclear ribonucleoprotein A1 and transcription-regulatory elements of viral RNA.

X Zhang1, H P Li, W Xue, M M Lai.   

Abstract

The heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) specifically binds to two transcription-regulatory elements, i.e., the leader and intergenic sequence, of the negative-strand (template-strand) RNA of mouse hepatitis virus (MHV) and may play a role in viral RNA transcription. Previous studies based on the defective-interfering RNAs of MHV suggested that these two RNA elements may interact with each other during transcription, although they do not have complementary sequences. In this study, we showed by an in vitro reconstitution assay that hnRNP A1 could mediate the formation of an RNP complex involving these two RNA elements. Both the RNA-binding domains and protein-interacting domain of hnRNP A1 contributed to the efficient formation of the RNP complex; however, the presence of the two RNA-binding domains alone, without the protein-interacting domain, also resulted in some RNP formation. Omission of hnRNP A1 in the reconstitution reaction abolished the RNP formation, and mutations of the IG sequences significantly inhibited the RNP formation. These findings suggest that the two cis-acting transcription-regulatory sequences of MHV RNA can interact with each other through the formation of an RNP complex involving a cellular protein hnRNP A1. This RNP complex may participate in MHV RNA transcription. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544136     DOI: 10.1006/viro.1999.9970

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication.

Authors:  X Shen; P S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

2.  Regulation of relative abundance of arterivirus subgenomic mRNAs.

Authors:  Alexander O Pasternak; Willy J M Spaan; Eric J Snijder
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 3.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

Review 4.  Biochemical aspects of coronavirus replication.

Authors:  Luis Enjuanes; Fernando Almazán; Isabel Sola; Sonia Zúñiga; Enrique Alvarez; Juan Reguera; Carmen Capiscol
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

5.  Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA.

Authors:  P Huang; M M Lai
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  The nucleocapsid protein of coronavirus mouse hepatitis virus interacts with the cellular heterogeneous nuclear ribonucleoprotein A1 in vitro and in vivo.

Authors:  Y Wang; X Zhang
Journal:  Virology       Date:  1999-12-05       Impact factor: 3.616

7.  Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis.

Authors:  Stephanie T Shi; Guann-Yi Yu; Michael M C Lai
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 8.  RNA-RNA and RNA-protein interactions in coronavirus replication and transcription.

Authors:  Isabel Sola; Pedro A Mateos-Gomez; Fernando Almazan; Sonia Zuñiga; Luis Enjuanes
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

Review 9.  Diverse roles of host RNA binding proteins in RNA virus replication.

Authors:  Zhenghe Li; Peter D Nagy
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

10.  Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus.

Authors:  S T Shi; P Huang; H P Li; M M Lai
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.